Glenmark Pharmaceuticals

Jun 19, 2015 at 14:18 | Source: CNBC-TV18
Speaking to CNBC-TV18 Surajit Pal, Pharma Analyst, Prabhudas Lilladher says that Glenmarks base rate would be lower than last year, as it receives Form 483 (observations) on recently inspected plants. Of the 45 new products 25-30 products will actualize by the next year.
Jun 19, 2015 at 09:19 | Source: CNBC-TV18
Deven Choksey of KR Choksey Shares & Securities is not sure whether the current rally is sustainable, but believes that the Nifty will remain rangebound between 8000 and 8400.
Jun 18, 2015 at 12:33 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends exiting Natco Pharma and advises buying Glenmark Pharma, Dr Reddy's Laboratories and Sun Pharma at lower levels.
Jun 18, 2015 at 09:15 | Source: CNBC-TV18
While Strides and Shasun merger gets into trouble, Glenmark gets into a spot post plant inspection.
Jun 17, 2015 at 15:19 | Source: CNBC-TV18
While maintaining that incrementally there have been a few macro positive in terms of coal dispatches and industrial output over the past few days, Naveen Kulkarni, Co-Head Research, PhillipCapital says he expects corporate earnings to revive meaningfully only during the second half of the year.
Jun 17, 2015 at 12:10 | Source: CNBC-TV18
According to Ajay Bodke of Prabhudas Lilladher, Glenmark Pharma is the top pick from the pharma space and favours Ashok Leyland over Tata Motors as an investment revival theme.
Jun 17, 2015 at 11:32 | Source: CNBC-TV18
Chandan Taparia of Anand Rathi Securities is of the view that one can buy Cipla 600 Call.
Jun 17, 2015 at 09:41 | Source: CNBC-TV18
Watch the interview of Chandan Taparia of Anand Rathi Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on the Futures and Options (F&O) side of the market and specific stocks.
Jun 16, 2015 at 16:52 | Source: CNBC-TV18
Sudip Bandopadhyay of Destimoney Securities is cautious on the market and would wait for the pronouncements by the Federal Reserve on Thursday before buying in wholesale.
Jun 15, 2015 at 17:46 | Source: PTI
Glenmark Pharmaceuticals USA has been granted final approval by the United States Food & Drug Administration (USFDA) for the "extended-cycle oral contraceptive Levonorgestrel and Ethinyl Estradiol tablets USP 0.15 mg/0.03 mg," Glenmark Pharmaceuticals said in a statement.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

8283 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8283 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8283 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8283 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd 2014

BSE/NSE Announcer

Platinum Member

8283 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th 2014

adviserbola

Platinum Member

364 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th 2014

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th 2014

Amrita Gaba

New Member

415 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th 2014

BSE/NSE Announcer

Platinum Member

8283 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.